Gamma Delta Lymphoma Audit

June 6, 2022

Retrospective review of Gamma Delta Lymphomas.
Analysis of demographics and Clinical outcomes (TTNT/PFS/OS)
Analysis of treatment lines (Induction/salvage/AutoSCT/AlloSCT)
Subgroup analysis
Review of current literature

Published 30 March 2022

Read here

doi: 10.21037/aol-21-41